United States · 
Who invested in Aralez Bio?
Aralez Bio's investors include Paladin Capital Group and Good Growth Capital.
United States · Series A startup
Who invested in Aralez Bio
Funding summaryUpdated 26 Oct 2026
$12Mraised across 1 round since 2024, from 1 source
- Latest round
- Series A, $12MOct 2024
- Investors
- 2
The rounds
- Oct 2024
Founders and team
From Aralez Bio's own website: 3 founders, 5 on the team.
Dr. Tina BovilleCo-founder and CEO
Dr. David RomneyCo-founder and CTO
Prof. Frances ArnoldCo-founder and Nobel Laureate
- Dr. Bjorn TraagVP of R&D
- Dr. Danielle ApplestoneVP of People (Fractional)
- Katie GreenfieldVP of Finance
- Peter HutchingsVP of Sales
- Dr. Lin LouieDirector of Process Chemistry
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
These 3 firms list Aralez Bio as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Aralez Bio
How much has Aralez Bio raised?
Aralez Bio has raised $12M across 1 round since 2024.
When did Aralez Bio last raise?
Aralez Bio's most recent round was a Series A of $12M in Oct 2024.
What was Aralez Bio's biggest round?
Its most recent round, $12M in Oct 2024, is also its largest on record.
Who backed Aralez Bio first?
Aralez Bio's first round on record, in Oct 2024, was backed by Paladin Capital Group and Good Growth Capital.
What stage is Aralez Bio at?
Aralez Bio's latest named round is a Series A, in Oct 2024.
Where is Aralez Bio based?
Aralez Bio is based in the United States.
Companies like Aralez Bio
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.